Conrex Pharmaceuticals
| About us | In 1991 dr. Hsieh discovered and patented a proprietary technology for an advanced drug delivery system, p. E. T. Enhancement technology), which could carry active therapeutic ingredients through the skin as well as mucous membranes, such as nasal and oral cavities. This transdermal and transmembrane delivery system has now been patented in 15 countries. Because of the remarkable discovery that ingredients could be delivered through the stratum corneum to deeper growing layers of the skin, dr. Hsieh of recognized that this unique delivery system could have many potential benefits to skin care. Our sesha line of skin care products fuse our proven and proprietary delivery technology with the highest-grade antioxidants and peptides available. This innovative technology applied to skin and hair received its own u. S. Patent in 1998, and has since obtained patents or has patents pending in 24 countries. Our branded skin care products are sold in the us, Europe, and Asia primarily through doctor's offices, medispas and spas. Our expertise in r&d also allows us to develop specially formulated skin care products for private use. We are also able to license our proprietary delivery technology for use in other skin and hair products. |
|---|---|
| Industry Focus | Pharmaceutical Chemicals, Skin Care |
| Business Type | Manufacturer |
| Products/Services | Pharmaceutical Chemicals,Skin Care |
| Our Markets | Worldwide |
| No. of Employees | 11 - 50 People |
| Annual Sales Range(USD) | Below US$1 Million |
| Year Established | 1985 |
| Legal Representative(CEO) | Phyllis Hsieh |
